FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311884329> ?p ?o ?g. }

• W4311884329 endingPage "2399" @default.
• W4311884329 startingPage "2399" @default.
• W4311884329 abstract "Background: The fragile X premutation carrier state (PM) (55-200 CGG repeats in the fragile X messenger ribonucleoprotein 1, FMR1 gene) is associated with several conditions, including fragile X-associated primary ovarian insufficiency (FXPOI) and fragile X-associated tremor ataxia (FXTAS), with current literature largely primarily investigating older PM individuals. The aim of this study was to identify the prevalence of fragile X-associated neurodevelopmental disorders (FXAND) in a sample of young PM individuals. Methods: This was a retrospective study conducted through a medical record review of PM individuals who were seen either for clinical concerns (probands, 45.9%) or identified through the cascade testing (non-probands, 54.1%) of an affected sibling with fragile X syndrome. Information on the presence of autism spectrum disorder, attention deficit hyperactivity disorder, anxiety, depression, long-term psychiatric medication intake, and cognitive function, based on standardized assessments, was obtained. Molecular data, including CGG repeat number and FMR1 mRNA levels, were also available for a subset of participants. Analysis included descriptive statistics and a test of comparison to describe the clinical profile of PM individuals pertinent to FXAND. Results: Participants included 61 individuals (52 males and 9 females) aged 7.8 to 20.0 years (mean 12.6 ± 3.4) with a mean full-scale IQ of 90.9 ± 22.7. The majority (N = 52; 85.2%) had at least one mental health disorder, with anxiety being the most common (82.0% of subjects), followed by ADHD (66.5%), and ASD (32.8%). Twenty-seven (87.1%) of non-probands also had at least one mental health condition, with probands having lower cognitive and adaptive skills than non-probands. ASD was present in 20 participants (17/52 males and 3/9 females; 15 probands) with significantly lower FSIQ in those with ASD (mean 73.5 vs. 98.0, p < 0.001). Participants with ASD had a higher number of long-term medications compared to those without (2.32 vs. 1.3, p = 0.002). Conclusions: Our findings indicate a high rate of FXAND diagnoses within a cohort of young PM individuals, including those identified via cascade testing, although this was not a population sample. An awareness of the entity of FXAND and the early recognition of the symptoms of associated conditions may facilitate timely and appropriate care for PM individuals." @default.
• W4311884329 created "2023-01-02" @default.
• W4311884329 creator A5011023379 @default.
• W4311884329 creator A5019810943 @default.
• W4311884329 creator A5072984368 @default.
• W4311884329 creator A5074856937 @default.
• W4311884329 creator A5083677550 @default.
• W4311884329 creator A5086196058 @default.
• W4311884329 date "2022-12-17" @default.
• W4311884329 modified "2023-09-30" @default.
• W4311884329 title "Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers" @default.
• W4311884329 cites W1226599482 @default.
• W4311884329 cites W1444401798 @default.
• W4311884329 cites W1970260137 @default.
• W4311884329 cites W1972177155 @default.
• W4311884329 cites W1977627907 @default.
• W4311884329 cites W1988498459 @default.
• W4311884329 cites W2005078842 @default.
• W4311884329 cites W2012322293 @default.
• W4311884329 cites W2033602142 @default.
• W4311884329 cites W2038561863 @default.
• W4311884329 cites W2069017725 @default.
• W4311884329 cites W2085198610 @default.
• W4311884329 cites W2088094988 @default.
• W4311884329 cites W2093461124 @default.
• W4311884329 cites W2097267337 @default.
• W4311884329 cites W2097787341 @default.
• W4311884329 cites W2101609880 @default.
• W4311884329 cites W2104346867 @default.
• W4311884329 cites W2116958987 @default.
• W4311884329 cites W2117973743 @default.
• W4311884329 cites W2120574495 @default.
• W4311884329 cites W2134810756 @default.
• W4311884329 cites W2138917845 @default.
• W4311884329 cites W2144550671 @default.
• W4311884329 cites W2153110788 @default.
• W4311884329 cites W2153868538 @default.
• W4311884329 cites W2171607710 @default.
• W4311884329 cites W2462102436 @default.
• W4311884329 cites W2511047665 @default.
• W4311884329 cites W2605596726 @default.
• W4311884329 cites W2614349964 @default.
• W4311884329 cites W2759433538 @default.
• W4311884329 cites W2889503576 @default.
• W4311884329 cites W2896114619 @default.
• W4311884329 cites W2901120330 @default.
• W4311884329 cites W3023632252 @default.
• W4311884329 cites W3115514053 @default.
• W4311884329 cites W3160713960 @default.
• W4311884329 cites W3216151710 @default.
• W4311884329 cites W4213436352 @default.
• W4311884329 cites W4246822396 @default.
• W4311884329 cites W4251941333 @default.
• W4311884329 cites W4283155961 @default.
• W4311884329 cites W4313371708 @default.
• W4311884329 doi "https://doi.org/10.3390/genes13122399" @default.
• W4311884329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36553666" @default.
• W4311884329 hasPublicationYear "2022" @default.
• W4311884329 type Work @default.
• W4311884329 citedByCount "4" @default.
• W4311884329 countsByYear W43118843292023 @default.
• W4311884329 crossrefType "journal-article" @default.
• W4311884329 hasAuthorship W4311884329A5011023379 @default.
• W4311884329 hasAuthorship W4311884329A5019810943 @default.
• W4311884329 hasAuthorship W4311884329A5072984368 @default.
• W4311884329 hasAuthorship W4311884329A5074856937 @default.
• W4311884329 hasAuthorship W4311884329A5083677550 @default.
• W4311884329 hasAuthorship W4311884329A5086196058 @default.
• W4311884329 hasBestOaLocation W43118843291 @default.
• W4311884329 hasConcept C104317684 @default.
• W4311884329 hasConcept C118552586 @default.
• W4311884329 hasConcept C139719470 @default.
• W4311884329 hasConcept C15744967 @default.
• W4311884329 hasConcept C162324750 @default.
• W4311884329 hasConcept C188997412 @default.
• W4311884329 hasConcept C205778803 @default.
• W4311884329 hasConcept C2776867660 @default.
• W4311884329 hasConcept C2777630245 @default.
• W4311884329 hasConcept C2778538070 @default.
• W4311884329 hasConcept C2779063550 @default.
• W4311884329 hasConcept C3020422209 @default.
• W4311884329 hasConcept C501734568 @default.
• W4311884329 hasConcept C54355233 @default.
• W4311884329 hasConcept C558461103 @default.
• W4311884329 hasConcept C71924100 @default.
• W4311884329 hasConcept C86803240 @default.
• W4311884329 hasConceptScore W4311884329C104317684 @default.
• W4311884329 hasConceptScore W4311884329C118552586 @default.
• W4311884329 hasConceptScore W4311884329C139719470 @default.
• W4311884329 hasConceptScore W4311884329C15744967 @default.
• W4311884329 hasConceptScore W4311884329C162324750 @default.
• W4311884329 hasConceptScore W4311884329C188997412 @default.
• W4311884329 hasConceptScore W4311884329C205778803 @default.
• W4311884329 hasConceptScore W4311884329C2776867660 @default.
• W4311884329 hasConceptScore W4311884329C2777630245 @default.
• W4311884329 hasConceptScore W4311884329C2778538070 @default.
• W4311884329 hasConceptScore W4311884329C2779063550 @default.
• W4311884329 hasConceptScore W4311884329C3020422209 @default.

• next